Current Management, Treatment Patterns and Outcomes of Metastatic Castrate Resistant Prostate Cancer Patients Treated With Radium-223
Phase of Trial: Phase IV
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- Acronyms Navigant
- Sponsors Bayer
- 09 Jan 2018 Status changed from recruiting to completed.
- 23 Nov 2017 Planned End Date changed from 15 Nov 2017 to 30 Nov 2017.
- 23 Nov 2017 Planned primary completion date changed from 15 Nov 2017 to 30 Nov 2017.